P1435: PRECLINICAL EVALUATION OF ZILOVERTAMAB-BASED ANTI-ROR1 CHIMERIC ANTIGEN RECEPTORS IN NK AND T CELLS

• S. Meinke,
• N. Kadri,
• S. Bi,
• B. Bostancioglu,
• C. Markey,
• J. B. Breitmeyer,
• A. Hussain,
• R. Krishnan,
• G. F. Kaufmann,
• E. Alici

Affiliations

S. Meinke

1 Department for Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden

N. Kadri

1 Department for Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden

S. Bi

2 Oncternal Therapeutics, San Diego, CA, United States of America

B. Bostancioglu

1 Department for Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden

C. Markey

2 Oncternal Therapeutics, San Diego, CA, United States of America

J. B. Breitmeyer

2 Oncternal Therapeutics, San Diego, CA, United States of America

A. Hussain

1 Department for Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden

R. Krishnan

2 Oncternal Therapeutics, San Diego, CA, United States of America

G. F. Kaufmann

2 Oncternal Therapeutics, San Diego, CA, United States of America

E. Alici

1 Department for Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden